| The Pharmaceutical Journal |
||
|
PDF* 85K |
|
Agenda for change
|
The IndustryLucrative "me-too" drugs a priorityFrom Mr U. G. Patel, MRPharmS In your editorial "Villains of the piece" (PJ, 3 May, p602), you seem to have taken up the cause of the powerful pharmaceutical industry. You say that companies spend a lot of time and money on research and development, and that this fact was glossed over in the Channel 4 programme. However, you do not mention that the programme talked about how most of this expensive research goes into the development of lucrative "me-too" drugs and not much is being done about diseases, such as malaria, where the profit for the industry is minimal. Umesh Patel |
|
|
Send your letter to The Editor |
Previous Topic (Allergies) |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site Map | Contact us